Literature DB >> 16377019

Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates.

Saïd Abes1, Donna Williams, Paul Prevot, Alain Thierry, Michael J Gait, Bernard Lebleu.   

Abstract

Splicing correction by steric-blocking oligonucleotides (ON) might lead to important clinical applications but requires efficient delivery to cell nuclei. The conjugation of short oligolysine tails has been used to deliver a correcting peptide nucleic acid (PNA) sequence in a positive readout assay in which ON hybridization to the cryptic splice site is strictly required for the expression of a luciferase reporter gene. We have investigated the mechanism of cellular uptake and the efficiency of a (Lys)(8)-PNA-Lys construction in this model system. Cell uptake is temperature-dependent and leads to sequestration of the conjugate in cytoplasmic vesicles in keeping with an endocytic mechanism of internalization. Accordingly a significant and sequence-specific splicing correction is achieved only in the presence of endosome-disrupting agents as chloroquine or 0.5 M sucrose. These endosome-disrupting agents do not affect the activity of free PNA, and do not increase (Lys)(8)-PNA-Lys uptake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377019     DOI: 10.1016/j.jconrel.2005.10.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  46 in total

1.  Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction.

Authors:  Helin Räägel; Margot Hein; Asko Kriiska; Pille Säälik; Anders Florén; Ülo Langel; Margus Pooga
Journal:  Cell Mol Life Sci       Date:  2013-07-13       Impact factor: 9.261

Review 2.  Cell penetrating peptides: overview and applications to the delivery of oligonucleotides.

Authors:  F Said Hassane; A F Saleh; R Abes; M J Gait; Bernard Lebleu
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

3.  Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens.

Authors:  Marta Gomarasca; Thaynan F C Martins; Lilo Greune; Philip R Hardwidge; M Alexander Schmidt; Christian Rüter
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Polymeric chloroquine as an inhibitor of cancer cell migration and experimental lung metastasis.

Authors:  Fei Yu; Jing Li; Ying Xie; Richard L Sleightholm; David Oupický
Journal:  J Control Release       Date:  2016-07-27       Impact factor: 9.776

5.  Cationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery.

Authors:  Huafeng Fang; Ke Zhang; Gang Shen; Karen L Wooley; John-Stephen A Taylor
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

6.  Synthesis and splice-redirecting activity of branched, arginine-rich peptide dendrimer conjugates of peptide nucleic acid oligonucleotides.

Authors:  Amer F Saleh; Andrey Arzumanov; Rachida Abes; David Owen; Bernard Lebleu; Michael J Gait
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

7.  Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy)phenyl]pyrrolocytosine.

Authors:  Jiaxin Hu; David W Dodd; Robert H E Hudson; David R Corey
Journal:  Bioorg Med Chem Lett       Date:  2009-09-06       Impact factor: 2.823

8.  miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.

Authors:  Martin M Fabani; Michael J Gait
Journal:  RNA       Date:  2007-12-11       Impact factor: 4.942

9.  Physico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacy.

Authors:  Sarah Resina; Paul Prevot; Alain R Thierry
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.